menu
    • menu

    Company profile for Orphazyme

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orphazyme was founded in 2009 with the objective to develop new therapies for patients suffering from protein-misfolding diseases with no or limited treatment options available. The company was based on a scientific discovery on the function of Heat-Shock Proteins (HSPs) by Thomas Kirkegaard Jensen and Professor Marja Jäättelä that was published in the scientific journal Nature. Since inception, Orphazyme has translated the...
    Orphazyme was founded in 2009 with the objective to develop new therapies for patients suffering from protein-misfolding diseases with no or limited treatment options available. The company was based on a scientific discovery on the function of Heat-Shock Proteins (HSPs) by Thomas Kirkegaard Jensen and Professor Marja Jäättelä that was published in the scientific journal Nature. Since inception, Orphazyme has translated the scientific discovery into a late-stage clinical development program.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OrphazymeDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Ole Maaløes Vej 3 DK-2200 Copenhagen N
    Telephone
    Telephone
    (+45) 39 17 82 72
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orphazyme.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orphazyme
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Orphazyme_AS

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Periodemeddelelse F¸rste Kvartal 2024
    Periodemeddelelse F¸rste Kvartal 2024

    14 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/14/2881122/0/en/Periodemeddelelse-F%C3%B8rste-Kvartal-2024.html

    GLOBENEWSWIRE
    14 May 2024
    Share Share
    Referat Fra Ordinr Generalforsamling Den 18. April 2024 Kl. 15:00
    Referat Fra Ordinr Generalforsamling Den 18. April 2024 Kl. 15:00

    18 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/18/2865515/0/en/Referat-Fra-Ordin%C3%A6r-Generalforsamling-Den-18-April-2024-Kl-15-00.html

    GLOBENEWSWIRE
    18 Apr 2024
    Share Share
    Indkaldelse Til Ordinær Generalforsamling Den 18. April 2024 Kl. 15:00
    Indkaldelse Til Ordinær Generalforsamling Den 18. April 2024 Kl. 15:00

    27 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/27/2853267/0/en/Indkaldelse-Til-Ordin%C3%A6r-Generalforsamling-Den-18-April-2024-Kl-15-00.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share
    Forel¸bige tal for 2023 og finansielle forventninger til 2024
    Forel¸bige tal for 2023 og finansielle forventninger til 2024

    25 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/25/2851788/0/en/Forel%C3%B8bige-tal-for-2023-og-finansielle-forventninger-til-2024.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    Change in management
    Change in management

    30 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/30/2678759/0/en/Change-in-management.html

    GLOBENEWSWIRE
    30 May 2023
    Share Share
    Major shareholder announcement
    Major shareholder announcement

    19 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/19/2672368/0/en/Major-shareholder-announcement.html

    GLOBENEWSWIRE
    19 May 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search